Delivery Order SPE2DR25D3013-SPE2DR26F6X8A
Award Date 1/22/26
Potential Completion Date 1/23/26
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,923.36 to AmerisourceBergen Drug Corp for the supply of Restasis 0.05% Eye Emulsion (60 units) on January 16, 2026, with an ultimate completion date of January 20, 2026. This is a firm fixed-price, non-set-aside contract with performance taking place in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc., which holds a significant indefinite delivery contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 22, 2026, for the supply of Restasis 0.05% Eye Emulsion in 30-unit quantities, with a ceiling value of $1,261.89 and an ultimate completion date of January 23, 2026. This award represents a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerSourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,340.35 to AmerisourceBergen Drug Corp for supply of Restasis 0.05% Eye Emulsion (60 count) on January 15, 2026, with a completion date of January 16, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 8, 2024, for the supply of Restasis 0.05% Eye Emulsion (60-count units) with a ceiling value of $2,822.04. This is a firm fixed-price delivery order with an ultimate completion date of November 12, 2024, and represents a competitively awarded contract with no set-aside designation. The award was made to AmerisourceBergen's Corporate Office division, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $18,986.97 to AmerisourceBergen Drug Corp for the supply of Restasis 0.05% Eye Emulsion (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical distributors....
- The Defense Logistics Agency awarded a $3,561.92 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,013.75 to AmerisourceBergen Drug Corp for Restasis 0.05% eye emulsion (30 single-use vials) on January 8, 2026, with an ultimate completion date of January 9, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. AmerisourceBergen Drug Corp operates as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,541.08 for Restasis 0.05% Eye Emulsion (30-count units) on May 6, 2025, with an ultimate completion date of May 7, 2025. This firm fixed-price delivery order represents a non-competitive procurement under a larger indefinite delivery contract vehicle. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $18,550.26 to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion (60 count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,008.88 to AmerisourceBergen Drug Corp for the supply of Restasis 0.05% Eye Emulsion in 30-unit quantities. The contract is non-competitive with no set-aside designation and carries a firm fixed-price structure with an ultimate completion date of January 21, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a leading pharmaceutical distributor serving federal medical procurement needs, particularly...